Company profile
Shanghai Simnova Biotechnology Co., Ltd.
Privately held: no public share price (Privately-held Shanghai/Boston clinical-stage cell-therapy biotech (CAR-T/CAR-NK), sister company of HKEX-listed Simcere Pharmaceutical Group but itself not separately listed; raised CNY 200M Series A+ (prnewswire, cbinsights). No independent public listing found. Sources: https://clinicaltrials.gov/study/NCT05346198 Entity resolved by asset-pipeline-v2.)
Assets
(2 total)
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.